Live Quote · NASDAQKLRAHealthcare· Biotechnology

Kailera Therapeutics, Inc.

$11.02▼ 4.84%($-0.56)
MKT CAP $1.43BNEXT EARNINGS Mar 3, 2027
50%
Bullish
TickerSpark Score
48/100
▌ Weak
87
Valuation
20
Profitability
20
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KLRA research report →

Analyst Price Target
$42.00+281.1% vs. today

Range $36 – $48

Price Chart

-55.46% · this period
$26.00$18.00$10.00Apr 17Aug 05Nov 19
52-Week Range7% of range
Low
$9.76
Current
$11.02
High
$28.23